Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2025 Jan-Dec:31:10760296251366420.
doi: 10.1177/10760296251366420. Epub 2025 Aug 6.

Relationship Between the Lactate-to-Albumin Ratio and 28-Day Overall Mortality in Critically Ill Patients with Pulmonary Embolism: A Retrospective Analysis of the MIMIC-IV Database

Affiliations
Observational Study

Relationship Between the Lactate-to-Albumin Ratio and 28-Day Overall Mortality in Critically Ill Patients with Pulmonary Embolism: A Retrospective Analysis of the MIMIC-IV Database

Junhao Xu et al. Clin Appl Thromb Hemost. 2025 Jan-Dec.

Abstract

BackgroundThe lactate-to-albumin ratio (LAR) has prognostic value in various clinical conditions, but its association with mortality in pulmonary embolism (PE) remains unclear. This study aims to investigate the relationship between LAR and 28-day all-cause mortality in PE patients.MethodsThis retrospective observational study used MIMIC-IV database, with 28-day mortality as the primary endpoint. Adjusted Cox models were used to assessed the LAR-mortality association, with subgroup analyses for stability. Kaplan-Meier curves estimated mortality across LAR tertiles. Restricted cubic spline(RCS) analysis evaluated nonlinearity. Receiver operating characteristic curves(ROC) and reclassification metrics were used to compare the predictive performance of LAR with the Pulmonary Embolism Severity Index (PESI).ResultsAmong the 319 included patients, 72 (22.6%) died within 28 days of admission. Non-survivors had significantly higher LAR levels. In adjusted Cox models, elevated LAR was independently associated with increased 28-day mortality risk. Kaplan-Meier curves showed significant survival differences across LAR tertiles. RCS analysis revealed a dose-response relationship with an inflection point around LAR 0.67. The ROC curve's C-statistic, validated by the DeLong test, highlights the superior performance of the LAR model, while the positive Integrated Discrimination Improvement and Net Reclassification Improvement values demonstrate its additional prognostic value over the PESI model. Subgroup analysis confirmed consistent findings across different patient groups.ConclusionElevated LAR was positively correlated with 28-day all-cause mortality in PE patients, maintaining prognostic value across subgroups. LAR showed potential as a practical prognostic indicator for PE risk stratification, warranting prospective validation and exploration of its clinical utility in PE management.

Keywords: MIMIC-IV database; lactate/Albumin ratio; mortality; prognosis; pulmonary embolism.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Schematic Diagram of Study Sample Selection Steps. MIMIC, Medical Information Mart for Intensive Care; PE, Pulmonary Embolism; ICU, Intensive Care Unit.
Figure 2.
Figure 2.
Kaplan-Meier Survival Analysis Curves for All-Cause Mortality Within 28-d of Hospitalization.
Figure 3.
Figure 3.
RCS Curves for the Relationship Between LAR and 28-d All Cause Mortality.
Figure 4.
Figure 4.
ROC Curve Comparison Between LAR and PESI Models.
Figure 5.
Figure 5.
Forest Plot for Subgroup Analysis of the Relationship Between 28-d All Cause Mortality and LAR.

Similar articles

References

    1. Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020;41(4):543-603. doi: 10.1093/eurheartj/ehz405 - DOI - PubMed
    1. Farmakis IT, Keller K, Barco S, Konstantinides SV, Hobohm L. From acute pulmonary embolism to post-pulmonary embolism sequelae: Functional and hemodynamic implications. Vasa. 2023;52(1):29-37. doi: 10.1024/0301-1526/a001042 - DOI - PubMed
    1. Sedhom R, Megaly M, Elbadawi A, et al. Contemporary national trends and outcomes of pulmonary embolism in the United States. Am J Cardiol. 2022;176:132-138. doi: 10.1016/j.amjcard.2022.03.060 - DOI - PubMed
    1. Hoskin S, Brieger D, Chow V, Kritharides L, Ng ACC. Trends in acute pulmonary embolism admission rates and mortality outcomes in Australia, 2002–2003 to 2017–2018: A retrospective cohort study. Thromb Haemost. 2021;121(09):1237-1245. doi: 10.1055/s-0041-1725932 - DOI - PubMed
    1. Jiménez D, Bikdeli B, Barrios D, et al. Epidemiology, patterns of care and mortality for patients with hemodynamically unstable acute symptomatic pulmonary embolism. Int J Cardiol. 2018;269:327-333. doi: 10.1016/j.ijcard.2018.07.059 - DOI - PubMed

Publication types

LinkOut - more resources